Canntab Therapeutics Limited
CTABF · OTC
2/28/2023 | 11/30/2022 | 8/31/2022 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$413 | -$1,031 | -$468 | -$1,444 |
| Dep. & Amort. | $92 | $172 | $139 | $189 |
| Deferred Tax | $0 | $292 | -$294 | $280 |
| Stock-Based Comp. | $0 | $16 | $46 | $0 |
| Change in WC | $57 | $259 | -$157 | -$46 |
| Other Non-Cash | $226 | $235 | $206 | $164 |
| Operating Cash Flow | -$38 | -$57 | -$527 | -$779 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$12 | $0 | -$13 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | $0 | $0 |
| Investing Cash Flow | -$3 | -$12 | $0 | -$13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2 | -$20 | -$19 | -$18 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $2 | -$20 | -$19 | -$18 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$39 | -$90 | -$546 | -$810 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55 | $145 | $691 | $1,501 |
| End Cash | $17 | $55 | $145 | $691 |
| Free Cash Flow | -$40 | -$70 | -$527 | -$792 |